全文获取类型
收费全文 | 1854篇 |
免费 | 254篇 |
国内免费 | 60篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 53篇 |
妇产科学 | 30篇 |
基础医学 | 187篇 |
口腔科学 | 25篇 |
临床医学 | 374篇 |
内科学 | 597篇 |
皮肤病学 | 18篇 |
神经病学 | 240篇 |
特种医学 | 249篇 |
外科学 | 97篇 |
综合类 | 38篇 |
一般理论 | 5篇 |
预防医学 | 60篇 |
眼科学 | 13篇 |
药学 | 49篇 |
中国医学 | 2篇 |
肿瘤学 | 127篇 |
出版年
2022年 | 8篇 |
2021年 | 14篇 |
2020年 | 8篇 |
2019年 | 7篇 |
2018年 | 22篇 |
2017年 | 9篇 |
2016年 | 9篇 |
2015年 | 22篇 |
2014年 | 26篇 |
2013年 | 47篇 |
2012年 | 58篇 |
2011年 | 63篇 |
2010年 | 45篇 |
2009年 | 48篇 |
2008年 | 43篇 |
2007年 | 92篇 |
2006年 | 55篇 |
2005年 | 58篇 |
2004年 | 61篇 |
2003年 | 62篇 |
2002年 | 61篇 |
2001年 | 60篇 |
2000年 | 70篇 |
1999年 | 45篇 |
1998年 | 75篇 |
1997年 | 58篇 |
1996年 | 81篇 |
1995年 | 55篇 |
1994年 | 64篇 |
1993年 | 63篇 |
1992年 | 48篇 |
1991年 | 44篇 |
1990年 | 56篇 |
1989年 | 70篇 |
1988年 | 75篇 |
1987年 | 71篇 |
1986年 | 59篇 |
1985年 | 65篇 |
1984年 | 35篇 |
1983年 | 36篇 |
1982年 | 27篇 |
1981年 | 28篇 |
1980年 | 30篇 |
1979年 | 25篇 |
1978年 | 28篇 |
1977年 | 24篇 |
1976年 | 13篇 |
1975年 | 17篇 |
1973年 | 4篇 |
1972年 | 7篇 |
排序方式: 共有2168条查询结果,搜索用时 15 毫秒
1.
Michael S Benninger Peter C Appelbaum James C Denneny David J Osguthorpe James A Stankiewicz 《Otolaryngology--head and neck surgery》2002,127(1):7-12
OBJECTIVE: Traditional assessments of the microbial flora associated with acute bacterial rhinosinusitis have relied on maxillary sinus punctures (taps) and culture. These taps are now considered the gold standard for obtaining cultures and are used as the method of identifying bacterial pathogens in antimicrobial trials. Maxillary sinus taps are limited by discomfort to the patients and technical concerns. Because of these factors, the standard of performing taps has limited antibiotic trials and microbial surveillance. Alternatives to maxillary sinus taps have been explored. STUDY DESIGN: We conducted a retrospective, systematic review of the literature from 1950 to 2000 of articles comparing culture techniques in the nose and paranasal sinuses for acute bacterial rhinosinusitis. RESULTS: Nasal cultures have poor correlation to maxillary sinus cultures, whereas there is 60% to 85% concordance between endoscopically guided middle meatal cultures and maxillary sinus cultures. These studies, however, are all limited by small sample sizes and therefore are inadequate to make any concrete recommendations regarding the relative role of endoscopically guided middle meatal cultures as a formal method of pathogen identification in acute bacterial rhinosinusitis. CONCLUSION: A formal prospective study with sufficient sample size to assess the concordance between the microbial flora of the maxillary sinus punctures and middle meatal cultures in acute rhinosinusitis is recommended. 相似文献
2.
3.
Yongkang Nie Qiang Li Feng Li Yonglin Pu Daniel Appelbaum Kunio Doi 《Journal of nuclear medicine》2006,47(7):1075-1080
Our objective was to develop and evaluate 3 semiautomatic computer-aided diagnostic (CAD) schemes for distinguishing between benign and malignant pulmonary nodules by use of features extracted from CT, 18F-FDG PET, and both CT and 18F-FDG PET. METHODS: We retrospectively collected 92 consecutive cases of pulmonary nodules (<3 cm) in patients who underwent both thoracic CT and whole-body PET/CT. Forty-two of the nodules were malignant and 50 benign, as confirmed by pathologic examination and clinical follow-up. The interval between CT and PET was less than 1 mo. Four clinical parameters, including patient age, sex, smoking status, and history of previous malignancy, were used for the CAD schemes. Sixteen CT features based on size, shape, margin, and internal structure of nodules were independently rated subjectively by 2 chest radiologists. Four PET features were viewed on a PET/CT workstation. CAD schemes based on clinical parameters together with CT features, PET features, and both CT and PET features were then used to differentiate benign from malignant nodules. Finally, the output from the CAD schemes was evaluated by use of receiver-operating-characteristic analysis. RESULTS: When we used clinical parameters and CT features as input units (CAD scheme 1), the area under the receiver-operating-characteristic curve (A(z) value) of the CAD scheme was 0.83. When we used clinical parameters and PET features as input units (CAD scheme 2), the A(z) value for the computer output was 0.91. However, when we used all data as input units (CAD scheme 3), the A(z) value for the computer output was 0.95. The performance of CAD scheme 3 was better than that of CAD scheme 1 or 2. A statistically significant difference existed between the A(z) values of CAD schemes 3 and 2 (P = 0.037) and between those of CAD schemes 3 and 1 (P = 0.015). CONCLUSION: Our CAD scheme based on both PET and CT was better able to differentiate benign from malignant pulmonary nodules than were the CAD schemes based on PET alone and CT alone. 相似文献
4.
5.
6.
7.
8.
9.
10.
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. 总被引:2,自引:0,他引:2
C Anasetti P J Martin R Storb F R Appelbaum P G Beatty J Davis K Doney H F Hill P Stewart K M Sullivan 《Transplantation》1992,54(5):844-851
Treatment with the monoclonal antibody OKT3 specific for the CD3 complex associated with the T cell antigen receptor can reverse acute rejection of human renal allografts. However, efficacy of anti-CD3 antibodies for treatment of patients with acute graft-versus-host disease after marrow transplantation has not been established. The dose-limiting side effects resulting from T cell activation induced by some anti-CD3 antibodies in vivo have discouraged their use for this application. We now report a phase I-II study of GVHD treatment with the anti-CD3 antibody BC3, a monoclonal murine IgG2b that, unlike OKT3, does not activate T cells. Fourteen patients were treated with BC3 after progression of acute GVHD despite treatment with cyclosporine and corticosteroids, and three patients received BC3 as primary treatment for GVHD. BC3 was administered at a dose of 0.1 or 0.2 mg/kg/day for seven or eight days. Five patients achieved complete resolution of GVHD, eight patients had partial improvement, two patients had no change, and two patients had progression of GVHD on therapy. Responses were sustained in 8 of 13 patients. Mild chills, fever, hypertension, and chest discomfort occurred in various combinations following 6 of 17 (35%) initial infusions of BC3 and following 4 of 99 (4%) subsequent infusions. In each instance it was possible to continue BC3 therapy without adjusting the dose or treatment schedule. In each patient treated, the absolute count of peripheral blood lymphocytes decreased transiently but returned to baseline within 22 hr after the first infusion. Circulating T cells had surface CD3 molecules saturated by the infused antibody in all but one patient. Four patients survived longer than one year after treatment with antibody BC3, and 13 patients died of infection or organ failure. Administration of the nonmitogenic anti-CD3 antibody BC3 was associated with improvement in the clinical manifestations of GVHD with minimal acute toxicity. Efficacy of antibody treatment did not depend on depletion of circulating T cells. Therefore, antibody BC3 may be achieving therapeutic immunosuppression by modulating T cell function. Controlled studies in patients treated earlier in the course of GVHD should determine whether antibody BC3 can improve survival. 相似文献